Professor Marek Malik is a globally recognized authority whose pioneering interdisciplinary work uniquely integrates mathematical precision with clinical cardiology expertise. He currently serves as Emeritus Professor of Cardiac Electrophysiology at the National Heart and Lung Institute, Imperial College London, where he maintains an active research program despite his emeritus status. Dr. Malik earned dual doctoral qualifications, securing a PhD in mathematics and computer science alongside his MD in internal medicine and cardiology, establishing the foundation for his distinctive approach to cardiac electrophysiology. His academic journey began at Charles University in Prague where he simultaneously held a chair in applied computer science and served as a Consultant at the University Hospital Department of Medicine before transitioning to London. At St George's Hospital Medical School, he developed his expertise in non-invasive electrophysiology, eventually leading the Non-Invasive Electrophysiology unit and chairing St Paul's Cardiac Electrophysiology program.
Dr. Malik's transformative research has fundamentally advanced electrocardiography and computerized ECG processing methodologies, with particular focus on acquired long QT syndrome and drug-induced cardiac repolarization changes. His innovative frameworks for assessing QTc interval stability have become indispensable standards in pharmaceutical development and cardiac safety evaluation worldwide, directly influencing regulatory practices for drug approval processes. As co-chair of the Independent Academic Task Force on Drug-Induced Torsade de Pointes, he shaped critical clinical guidelines that revolutionized how medications are evaluated for cardiac safety implications. With an exceptional scholarly record featuring 11 authoritative monographs and textbooks alongside more than 400 peer-reviewed publications, his work has established new paradigms in cardiac electrophysiological assessment and interpretation.
His professional eminence is reflected in prestigious fellowships within the American College of Cardiology, European Society of Cardiology, and Heart Rhythm Society, signifying his international stature as a field leader. Since 2009, Dr. Malik has contributed as an Honorary ORISE Fellow of the Food and Drug Administration in Washington, DC, providing essential expertise on cardiac safety evaluation to regulatory authorities globally. Currently active as a Senior Research Investigator at Imperial College, he continues advancing methodologies for heart rate variability analysis and drug-induced QT interval assessment with contemporary relevance. Dr. Malik's enduring scholarly contributions have cemented his legacy as a pivotal figure whose work continues to shape cardiac safety standards and electrophysiological research methodologies across academic, pharmaceutical, and regulatory domains worldwide.
